These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11842107)

  • 1. The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation.
    Birke M; Schreiner S; García-Cuéllar MP; Mahr K; Titgemeyer F; Slany RK
    Nucleic Acids Res; 2002 Feb; 30(4):958-65. PubMed ID: 11842107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to nonmethylated CpG DNA is essential for target recognition, transactivation, and myeloid transformation by an MLL oncoprotein.
    Ayton PM; Chen EH; Cleary ML
    Mol Cell Biol; 2004 Dec; 24(23):10470-8. PubMed ID: 15542854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mixed lineage leukemia (MLL) protein involved in 11q23 translocations contains a domain that binds cruciform DNA and scaffold attachment region (SAR) DNA.
    Broeker PL; Harden A; Rowley JD; Zeleznik-Le N
    Curr Top Microbiol Immunol; 1996; 211():259-68. PubMed ID: 8585957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.
    So CW; Cleary ML
    Mol Cell Biol; 2002 Sep; 22(18):6542-52. PubMed ID: 12192052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein.
    Xia ZB; Anderson M; Diaz MO; Zeleznik-Le NJ
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8342-7. PubMed ID: 12829790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.
    Zeleznik-Le NJ; Harden AM; Rowley JD
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10610-4. PubMed ID: 7938000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator.
    Schreiner SA; García-Cuéllar MP; Fey GH; Slany RK
    Leukemia; 1999 Oct; 13(10):1525-33. PubMed ID: 10516753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
    Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
    J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3.
    García-Cuéllar MP; Zilles O; Schreiner SA; Birke M; Winkler TH; Slany RK
    Oncogene; 2001 Jan; 20(4):411-9. PubMed ID: 11313972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.
    Zeisig DT; Bittner CB; Zeisig BB; García-Cuéllar MP; Hess JL; Slany RK
    Oncogene; 2005 Aug; 24(35):5525-32. PubMed ID: 15856011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
    So CW; Lin M; Ayton PM; Chen EH; Cleary ML
    Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.
    Ayton PM; Cleary ML
    Oncogene; 2001 Sep; 20(40):5695-707. PubMed ID: 11607819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins.
    Cross SH; Meehan RR; Nan X; Bird A
    Nat Genet; 1997 Jul; 16(3):256-9. PubMed ID: 9207790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23).
    Ono R; Taki T; Taketani T; Taniwaki M; Kobayashi H; Hayashi Y
    Cancer Res; 2002 Jul; 62(14):4075-80. PubMed ID: 12124344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MLL targets SET domain methyltransferase activity to Hox gene promoters.
    Milne TA; Briggs SD; Brock HW; Martin ME; Gibbs D; Allis CD; Hess JL
    Mol Cell; 2002 Nov; 10(5):1107-17. PubMed ID: 12453418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small oligomerization domain of gephyrin converts MLL to an oncogene.
    Eguchi M; Eguchi-Ishimae M; Greaves M
    Blood; 2004 May; 103(10):3876-82. PubMed ID: 14751928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.
    Hayette S; Cornillet-Lefebvre P; Tigaud I; Struski S; Forissier S; Berchet A; Doll D; Gillot L; Brahim W; Delabesse E; Magaud JP; Rimokh R
    Cancer Res; 2005 Aug; 65(15):6521-5. PubMed ID: 16061630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common mechanism for oncogenic activation of MLL by forkhead family proteins.
    So CW; Cleary ML
    Blood; 2003 Jan; 101(2):633-9. PubMed ID: 12393557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
    Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
    Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+.
    García-Cuéllar MP; Schreiner SA; Birke M; Hamacher M; Fey GH; Slany RK
    Oncogene; 2000 Mar; 19(14):1744-51. PubMed ID: 10777208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.